Phase II study of everolimus in metastatic urothelial cancer

OBJECTIVE: To assess the efficacy and tolerability of everolimus in advanced urothelial carcimoma (UC). PATIENTS AND METHODS: The present study comprised a single-arm, non-randomized study in which all patients received everolimus 10 mg orally once daily continuously (one cycle = 4 weeks). In total,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Milowsky, Matthew I., Iyer, Gopa, Regazzi, Ashley M., Al-Ahmadie, Hikmat, Gerst, Scott R., Ostrovnaya, Irina, Gellert, Lan L., Kaplan, Rana, Garcia-Grossman, Ilana R., Pendse, Deepa, Balar, Arjun V., Flaherty, Anne Marie, Trout, Alisa, Solit, David B., Bajorin, Dean F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4020005/
https://ncbi.nlm.nih.gov/pubmed/23551593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1464-410X.2012.11720.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados